Study on abnormal glucose and lipid metabolism among 771 in-patients with ischemic stroke
Zhang, Y.-p.; Zhang, Z.-x.; Shen, M.-y.; Deng, X.-q.; Ding, Z.-q.; Wang, J.-s.
Zhonghua Liu Xing Bing Xue Za Zhi 30(11): 1194-1197
2009
ISSN/ISBN: 0254-6450 PMID: 20193594 Document Number: 632872
To study the epidemiological characteristics of abnormal glucose and lipid metabolism in in-patients with ischemic stroke. A total number of 771 in-patients with ischemic stroke, hospitalized in the Department of Neurology/Endocrinology from Changzhou No. 2 Hospital from April 2007 to April 2008 were enrolled in this study. After identifying the condition of glucose metabolism, all diagnosis-undetermined patients received oral glucose tolerance test. Among in-patients with ischemic stroke, 41.8% of the patients were finally diagnosed as diabetes, with 23.4% classified as 'impaired glucose tolerance'. The prevalence of 'abnormal glucose metabolism' was 65.2% in total. If diabetes in the in-patients with ischemic stroke was diagnosed only by fast plasma glucose instead of oral glucose tolerance test, 58.5% diabetic patients would have been misdiagnosed. Abnormal lipid metabolism existed in inpatients with cerebral ischemic stroke were noticed. These abnormalities of lipid metabolism were mainly consisting of increased triglyceride and decreased HDL-C cholesterol. The majority of in-patients with ischemic stroke appeared to have had abnormal glucose and lipid metabolism. It seemed necessary to promptly and correctly diagnose these patients with abnormal glucose metabolism by oral glucose tolerance test to reduce the chances of developing the recurrence of stroke.